This chapter does not require a health care practitioner who is licensed in the State or a health care provider that is licensed in the State to provide any service related to an investigational drug, biological product or device.
Optional participation of health care practitioners and providers
22 M.R.S. § 2677, under ACCESS TO INVESTIGATIONAL TREATMENTS FOR TERMINALLY ILL PATIENTS.
22 M.R.S. § 2677